Human CD4 + HLA‐G + regulatory T cells are potent suppressors of graft‐versus‐host disease in vivo
Open Access
- 17 April 2014
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 28 (8) , 3435-3445
Abstract
CD4 + T cells expressing the immunotolerizing molecule HLA‐G have been described as a unique human thymus‐derived regulatory T (tT reg ) cell subset involved in immunoregulation and parenchymal homeostasis during infectious and autoimmune inflammation. We compared properties and molecular characteristics of human CD4 + HLA‐G + with those of CD4 + CD25 + FoxP3‐expressing tT reg cells using in vitro studies of T‐cell receptor (TCR) signaling, single‐cell electrophysiology, and functional in vivo studies. Both tT reg populations are characterized by alterations in proximal‐signaling pathways on TCR stimulation and a hyperpolarization of the plasma membrane when compared to conventional CD4 + T cells. However, both clearly differ in phenotype and pattern of secreted cytokines, which results in distinct mechanisms of suppression: While CD4 + HLA‐G + cells secrete high levels of inhibitory molecules (IL‐10, soluble HLA‐G, IL‐35), CD4 + CD25 + FoxP3 + cells express these molecules at significantly lower levels and seem to exert their function mainly in a contact‐dependent manner via cyclic adenosine‐monophosphate. Finally we demonstrate that human CD4 + HLA‐G + tT reg cells significantly ameliorated graft‐versus‐host disease in a humanized mouse model as a first proof of their in vivo relevance. Our data further characterize and establish CD4 + HLA‐G + cells as a potent human tT reg population that can modulate polyclonal adaptive immune responses in vivo and thus being a promising candidate for potential clinical applications in the future.—Pankratz, S., Bittner, S., Herrmann, A. M., Schuhmann, M. K., Ruck, T., Meuth, S. G., Wiendl, H. Human CD4 + HLA‐G + regulatory T cells are potent suppressors of graft‐versus‐host disease in vivo . FASEB J. 28, 3435‐3445 (2014). www.fasebj.orgKeywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (FKZ 01GI0907)
- Deutsche Forschungsgemeinschaft
- Westfälische Wilhelms-Universität Münster
This publication has 45 references indexed in Scilit:
- Regulatory T cells: recommendations to simplify the nomenclatureNature Immunology, 2013
- Reduced Expression of FOXP3 and Regulatory T-Cell Function in Severe Forms of Early-onset Autoimmune EnteropathyGastroenterology, 2010
- Defective regulatory and effector T cell functions in patients with FOXP3 mutationsJournal of Clinical Investigation, 2006
- Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-selfNature Immunology, 2005
- NaturallyArisingCD4+RegulatoryT Cells forImmunologicSelf-Tolerance andNegativeControl ofImmuneResponsesAnnual Review of Immunology, 2004
- Foxp3 programs the development and function of CD4+CD25+ regulatory T cellsNature Immunology, 2003
- CD4+CD25high Regulatory Cells in Human Peripheral BloodThe Journal of Immunology, 2001
- Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral BloodJournal of Experimental Medicine, 2001
- Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human BloodJournal of Experimental Medicine, 2001
- Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activityin vitroEuropean Journal of Immunology, 2001